Hernández Prat, A., Rodriguez-Vida, A., Cardona, L., Qin, M., Arpí Llucià, O., Soria-Jiménez, L., . . . Bellmunt Molins, J. (2025). Enhancing immunotherapy through PD-L1 upregulation: The promising combination of anti-PD-L1 plus mTOR inhibitors.
Citación estilo ChicagoHernández Prat, Anna, et al. Enhancing Immunotherapy Through PD-L1 Upregulation: The Promising Combination of Anti-PD-L1 Plus MTOR Inhibitors. 2025.
Cita MLAHernández Prat, Anna, et al. Enhancing Immunotherapy Through PD-L1 Upregulation: The Promising Combination of Anti-PD-L1 Plus MTOR Inhibitors. 2025.
Precaución: Estas citas no son 100% exactas.